Synergistic Enhancement of Cisplatin Cytotoxicity by SN‐38, an Active Metabolite of CPT‐11, for Cisplatin‐resistant HeLa Cells

A cisplatin (cis‐diamininedichloroplatinuin(II); CDDP)‐resistant HeLa cell line (HeLa/CDDP cells), which showed more than 8‐fold resistance to CDDF compared to the parent cells, was newly established for this study. HeLa/CDDP cells accumulated 50% less platinum than the parent cells. There was no di...

Descripción completa

Detalles Bibliográficos
Autores principales: Minagawa, Yukihisa, Kigawa, Junzo, Ishihara, Hiroshi, Itamochi, Hiroaki, Terakawa, Naoki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 1994
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919584/
https://www.ncbi.nlm.nih.gov/pubmed/7961127
http://dx.doi.org/10.1111/j.1349-7006.1994.tb02976.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919584/
https://www.ncbi.nlm.nih.gov/pubmed/7961127
http://dx.doi.org/10.1111/j.1349-7006.1994.tb02976.x

Ejemplares similares